Harm Jan Bogaard Selected Research

Bosentan (Tracleer)

8/2015

Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harm Jan Bogaard Research Topics

Disease

26	Pulmonary Hypertension 10/2022 - 01/2013
23	Pulmonary Arterial Hypertension 04/2022 - 07/2012
9	Inflammation (Inflammations) 01/2022 - 12/2013
8	Hypoxia (Hypoxemia) 01/2021 - 01/2013
7	Pulmonary Embolism 12/2021 - 01/2018
6	COVID-19 02/2022 - 01/2021
6	Heart Failure 01/2022 - 10/2019
6	Vascular Remodeling 01/2021 - 12/2013
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2022 - 01/2021
3	Thrombosis (Thrombus) 01/2022 - 01/2020
3	Hypertrophy 01/2021 - 05/2016
2	Neoplasms (Cancer) 09/2022 - 06/2014
2	Infections 05/2021 - 01/2021
2	Critical Illness (Critically Ill) 01/2021 - 01/2021
2	Familial Primary Pulmonary Hypertension 11/2020 - 12/2013
2	Systemic Scleroderma (Systemic Sclerosis) 10/2014 - 12/2013
1	Pulmonary Edema 02/2022
1	Hemorrhage 01/2022
1	Disease Progression 05/2021
1	Clinical Deterioration 05/2021
1	Thromboinflammation 05/2021
1	Atrial Fibrillation 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Obesity 01/2020
1	Acute Lung Injury 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2018
1	Fibrosis (Cirrhosis) 05/2016
1	Idiopathic Pulmonary Fibrosis 01/2016
1	Cardiomegaly (Heart Hypertrophy) 06/2014

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2019
6	Semaxinib (SU5416)IBA 01/2021 - 06/2014
5	AnticoagulantsIBA 10/2022 - 01/2020
5	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2022 - 05/2016
5	MonocrotalineIBA 01/2020 - 06/2014
4	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2022 - 05/2016
4	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 12/2021 - 01/2019
3	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2020 - 05/2016
2	Imatinib Mesylate (Gleevec)FDA Link 02/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	Complement System Proteins (Complement)IBA 05/2021 - 01/2021
2	CytokinesIBA 01/2021 - 04/2018
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2020 - 01/2019
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2019 - 01/2013
2	Carbon MonoxideIBA 10/2014 - 12/2013
1	AS 195IBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	hydralazine 4-anisaldehyde hydrazoneIBA 04/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	von Willebrand FactorIBA 01/2022
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2021
1	InterleukinsIBA 05/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	Clorgyline (Clorgiline)IBA 01/2021
1	ChemokinesIBA 01/2021
1	LigandsIBA 01/2021
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 11/2020
1	Mineralocorticoid Receptor AntagonistsIBA 10/2020
1	Bisoprolol (Concor)FDA LinkGeneric 04/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	FibrinIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	bosutinibIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Bone Morphogenetic Protein ReceptorsIBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2019
1	Neprilysin (Neutral Endopeptidase)IBA 10/2019
1	apabetaloneIBA 10/2019
1	Orphan Nuclear ReceptorsIBA 01/2019
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	Simendan (Levosimendan)IBA 10/2017
1	nintedanibIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2015
1	Endothelin A ReceptorIBA 08/2015
1	macitentanIBA 08/2015
1	Endothelin-1 (Endothelin 1)IBA 08/2015
1	Bosentan (Tracleer)FDA Link 08/2015
1	ambrisentan FDA Link 08/2015
1	Nebivolol FDA Link 02/2015
1	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2014
1	Histone Deacetylase InhibitorsIBA 06/2014

Therapy/Procedure

8	Therapeutics 05/2021 - 03/2015
5	Endarterectomy (Thromboendarterectomy) 01/2022 - 01/2014
2	Artificial Respiration (Mechanical Ventilation) 02/2022 - 01/2021
1	Length of Stay 02/2022
1	Catheters 02/2022